Ahmad Anis, Kumar Mallela Shamroop, Ansari Saba, Alnukhali Mohammed, Ali Misha, Merscher Sandra, Pollack Alan, H Zeidan Youssef, Fornoni Alessia, Marples Brian
{"title":"Radiation-induced nephrotoxicity: Role of SMPDL3b.","authors":"Ahmad Anis, Kumar Mallela Shamroop, Ansari Saba, Alnukhali Mohammed, Ali Misha, Merscher Sandra, Pollack Alan, H Zeidan Youssef, Fornoni Alessia, Marples Brian","doi":"10.1016/j.ijrobp.2024.11.105","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Radiation nephropathy (RN) can be a significant late complication after radiotherapy for abdominal and paraspinal tumors. The mechanisms for the development of RN are thought to involve disruption of podocyte function, leading to podocyte cell death and, finally, impaired renal function. This study investigated the mechanistic role of SMPDL3b in regulating podocyte injury and renal function after irradiation. The aim of the study was to investigate the potential linkage between (1) RT-induced renal dysfunction and podocyte SMPDL3b expression and (2) RT-induced podocyte injury and expansion of the glomerular basement membrane (GBM).</p><p><strong>Methods: </strong>SMPDL3b WT, siSMPDL3b, and SMPDL3b-overexpressing podocytes were irradiated in cell culture, and cell death was assessed. SMPDL3b WT and podocyte-specific SMPDL3b KO (pSMPDL3b KO) mice were treated with focal bilateral kidney X-irradiation (14 Gy, or 6 × 5Gy), and podocyte apoptosis, renal function parameters, glomerular filtration rate (GFR), glomerular histology, and GBM ultrastructural changes via transmission electron microscopy were assessed.</p><p><strong>Results: </strong>Following RT treatment, a notable decrease in SMPDL3b expression was observed, accompanied by heightened levels of DNA damage, cytoskeletal alterations, and apoptotic events in cultured podocytes. SMPDL3b overexpression notably prevented DNA damage and apoptosis in cultured podocytes. Additionally, in vivo, RT exposure led to a significant decline in SMPDL3b expression, podocyte count, and renal function while concomitantly elevating glomerular basement membrane (GBM) thickness, mesangial expansion, and renal fibrosis at the 20-week post-RT. Furthermore, in vivo, rituximab pretreatment before RT prevented SMPDL3b downregulation, podocyte loss, mesangial expansion, GBM expansion, and renal fibrosis and ultimately enhanced renal function post-RT.</p><p><strong>Conclusion: </strong>Our findings collectively suggest a novel function for SMPDL3b in orchestrating the DNA damage response triggered by radiation. This study proposes that SMPDL3b exerts a regulatory influence on the repair of double-strand breaks (DSBs) within podocytes, consequently averting podocyte loss, glomerular basement membrane (GBM) expansion, and the onset of radiation nephropathy.</p>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":" ","pages":""},"PeriodicalIF":6.4000,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijrobp.2024.11.105","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Radiation nephropathy (RN) can be a significant late complication after radiotherapy for abdominal and paraspinal tumors. The mechanisms for the development of RN are thought to involve disruption of podocyte function, leading to podocyte cell death and, finally, impaired renal function. This study investigated the mechanistic role of SMPDL3b in regulating podocyte injury and renal function after irradiation. The aim of the study was to investigate the potential linkage between (1) RT-induced renal dysfunction and podocyte SMPDL3b expression and (2) RT-induced podocyte injury and expansion of the glomerular basement membrane (GBM).
Methods: SMPDL3b WT, siSMPDL3b, and SMPDL3b-overexpressing podocytes were irradiated in cell culture, and cell death was assessed. SMPDL3b WT and podocyte-specific SMPDL3b KO (pSMPDL3b KO) mice were treated with focal bilateral kidney X-irradiation (14 Gy, or 6 × 5Gy), and podocyte apoptosis, renal function parameters, glomerular filtration rate (GFR), glomerular histology, and GBM ultrastructural changes via transmission electron microscopy were assessed.
Results: Following RT treatment, a notable decrease in SMPDL3b expression was observed, accompanied by heightened levels of DNA damage, cytoskeletal alterations, and apoptotic events in cultured podocytes. SMPDL3b overexpression notably prevented DNA damage and apoptosis in cultured podocytes. Additionally, in vivo, RT exposure led to a significant decline in SMPDL3b expression, podocyte count, and renal function while concomitantly elevating glomerular basement membrane (GBM) thickness, mesangial expansion, and renal fibrosis at the 20-week post-RT. Furthermore, in vivo, rituximab pretreatment before RT prevented SMPDL3b downregulation, podocyte loss, mesangial expansion, GBM expansion, and renal fibrosis and ultimately enhanced renal function post-RT.
Conclusion: Our findings collectively suggest a novel function for SMPDL3b in orchestrating the DNA damage response triggered by radiation. This study proposes that SMPDL3b exerts a regulatory influence on the repair of double-strand breaks (DSBs) within podocytes, consequently averting podocyte loss, glomerular basement membrane (GBM) expansion, and the onset of radiation nephropathy.
期刊介绍:
International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.
This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.